According to a new research conducted at the Geneva-Lausanne School of Pharmacy, University of Basel published in the Journal of Medicinal Chemistry has identified the ultra sophisticated computerized tools for successful identification of toxic molecules responsible for pathogen. The malaria parasite is specifically harmful since it is developed for resistance treatments. The most harmful form of malaria is due to infection from Plasmodium falciparum. The abolition of this parasite is more difficult.
The lead researcher, Didier Picard, professor of biology at the Faculty of Sciences of UNIGE, Switzerland, explains, “These recently patented molecules are part of a group of compounds related to the 7-azaindoles, which exclusively bind the HSP90 of the parasite, but not the human form. The next step will be to fine-tune them in order to perform clinical tests.”
This molecule will work successfully against the most dangerous molecules hence prevent people dying from this disease.